PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
NKT.CO vs. NOVO-B.CO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

NKT.CO vs. NOVO-B.CO

Last updated Jun 5, 2026

NKT.CO (NKT A/S) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. NKT.CO operates in Electrical Equipment & Parts (Industrials), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, NKT.CO returned 22.07%/yr vs 6.71%/yr for NOVO-B.CO. At a 0.20 correlation, their price movements are largely independent.

Performance

NKT.CO vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in NKT A/S (NKT.CO) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NKT.CO achieves a 27.74% return, which is significantly higher than NOVO-B.CO's -9.72% return. Over the past 10 years, NKT.CO has outperformed NOVO-B.CO with an annualized return of 22.07%, while NOVO-B.CO has yielded a comparatively lower 6.71% annualized return.

NKT.CO

1D
-1.92%
1M
7.77%
YTD
27.74%
6M
29.69%
1Y
94.10%
3Y*
37.41%
5Y*
31.00%
10Y*
22.07%

NOVO-B.CO

1D
4.43%
1M
-3.12%
YTD
-9.72%
6M
-5.16%
1Y
-37.68%
3Y*
-17.20%
5Y*
5.13%
10Y*
6.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NKT.CO vs. NOVO-B.CO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
NKT.CO
NKT A/S		27.74%55.20%10.93%29.06%24.02%16.37%91.04%80.78%-68.60%20.78%
NOVO-B.CO
Novo Nordisk A/S		-9.72%-46.40%-9.59%50.74%29.53%75.62%12.77%32.92%-8.60%35.35%

Correlation

The correlation between NKT.CO and NOVO-B.CO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since May 11, 1993

0.20

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

NKT A/S

Novo Nordisk A/S

Often compared with NKT.CO:
NKT.CO vs. REGNNKT.CO vs. PFENKT.CO vs. SND.DENKT.CO vs. HH.CONKT.CO vs. DFDS.CONKT.CO vs. TGS.OLNKT.CO vs. KCR.HE
Often compared with NOVO-B.CO:
NOVO-B.CO vs. SPYNOVO-B.CO vs. LLYNOVO-B.CO vs. QQQNOVO-B.CO vs. NOV.DENOVO-B.CO vs. SAABYNOVO-B.CO vs. LLY.DENOVO-B.CO vs. MONC.MI

Return for Risk

NKT.CO vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
NKT.CO
NKT.CO Risk / Return Rank: 9494
Overall Rank
NKT.CO Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
NKT.CO Sortino Ratio Rank: 9393
Sortino Ratio Rank
NKT.CO Omega Ratio Rank: 9090
Omega Ratio Rank
NKT.CO Calmar Ratio Rank: 9696
Calmar Ratio Rank
NKT.CO Martin Ratio Rank: 9696
Martin Ratio Rank
NOVO-B.CO
NOVO-B.CO Risk / Return Rank: 1616
Overall Rank
NOVO-B.CO Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
NOVO-B.CO Sortino Ratio Rank: 1515
Sortino Ratio Rank
NOVO-B.CO Omega Ratio Rank: 1414
Omega Ratio Rank
NOVO-B.CO Calmar Ratio Rank: 1616
Calmar Ratio Rank
NOVO-B.CO Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NKT.CO vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NKT A/S (NKT.CO) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

NKT.CONOVO-B.CODifference
Sharpe ratioReturn per unit of total volatility
2.61
-0.70

+3.32

Sortino ratioReturn per unit of downside risk
3.70
-0.75

+4.44

Omega ratioGain probability vs. loss probability

1.43

0.89

+0.54

Calmar ratioReturn relative to maximum drawdown

8.27

-0.69

+8.96

Martin ratioReturn relative to average drawdown

22.26

-1.03

+23.29

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NKT.CO vs. NOVO-B.CO - Sharpe Ratio Comparison

The current NKT.CO Sharpe Ratio is 2.61, which is higher than the NOVO-B.CO Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of NKT.CO and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

NKT.CONOVO-B.CODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.61

-0.70

+3.32

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.86

0.13

+0.73

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.56

0.21

+0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

0.53

-0.15

Drawdowns

NKT.CO vs. NOVO-B.CO - Drawdown Comparison

The maximum NKT.CO drawdown since its inception was -91.71%, which is greater than NOVO-B.CO's maximum drawdown of -76.75%. Use the drawdown chart below to compare losses from any high point for NKT.CO and NOVO-B.CO.

Loading charts...

Drawdown Indicators

NKT.CONOVO-B.CODifference

Max Drawdown

Largest peak-to-trough decline

-91.71%

-76.75%

-14.96%

Max Drawdown (1Y)

Largest decline over 1 year

-11.63%

-54.94%

+43.31%

Max Drawdown (3Y)

Largest decline over 3 years

-34.39%

-76.75%

+42.36%

Max Drawdown (5Y)

Largest decline over 5 years

-34.39%

-76.75%

+42.36%

Max Drawdown (10Y)

Largest decline over 10 years

-74.42%

-76.75%

+2.33%

Current Drawdown

Current decline from peak

-8.27%

-70.51%

+62.24%

Average Drawdown

Average peak-to-trough decline

-33.50%

-16.01%

-17.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.82%

36.70%

-31.88%

Volatility

NKT.CO vs. NOVO-B.CO - Volatility Comparison

NKT A/S (NKT.CO) has a higher volatility of 11.27% compared to Novo Nordisk A/S (NOVO-B.CO) at 9.89%. This indicates that NKT.CO's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

NKT.CONOVO-B.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

11.27%

9.89%

+1.38%

Volatility (6M)

Calculated over the trailing 6-month period

23.41%

39.23%

-15.82%

Volatility (1Y)

Calculated over the trailing 1-year period

36.79%

54.38%

-17.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.08%

38.71%

-2.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.03%

32.58%

+7.45%

Dividends

NKT.CO vs. NOVO-B.CO - Dividend Comparison

NKT.CO has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.12%.

PositionTTM20252024202320222021202020192018201720162015
NKT.CO
NKT A/S		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.96%0.80%1.12%
NOVO-B.CO
Novo Nordisk A/S		4.12%3.58%1.59%1.01%1.19%1.27%2.02%2.11%2.64%2.27%3.69%1.25%

Financials

NKT.CO vs. NOVO-B.CO - Financials Comparison

This section allows you to compare key financial metrics between NKT A/S and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Values in DKK except per share items

Frequently Asked Questions

NKT.CO and NOVO-B.CO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NKT.CO and NOVO-B.CO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer